Immunologic Dysregulation and Hypercoagulability as a Pathophysiologic Background in COVID-19 Infection and the Immunomodulating Role of Colchicine.

J Clin Med · 2021 · PMC8584586 · PMID 34768648

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

did not reach statistical significancep = 0.08so close (0.05 < p ≤ 0.1)

At 28 days of follow-up, the effect of colchicine on the co-primary endpoint of death or mechanical ventilation did not reach statistical significance (HR: 0.83; 95% CI: 0.67–1.02; p = 0.08).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.